Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
At close: Sep 4, 2026 · 4:00 PM EDT

Incyte (INCY) Change in Receivables (2010 - 2026)

Incyte's (INCY) quarterly Change in Receivables came in at $73.8 million in Q2 2026, up 264.8% on a YoY basis from $20.2 million in Q2 2025, and up 173.04% quarter-over-quarter from $27.0 million in Q1 2026.

Analysis

Incyte (INCY) Change in Receivables (2010 - 2026) Analysis & Trends

Incyte (INCY) has reported Change in Receivables for 17 consecutive years, with $73.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Receivables rose 264.8% year-over-year to $73.8 million; the trailing twelve-month figure through Jun 2026 stood at $282.3 million (up 167.94% YoY), and the FY2025 full-year result was $170.8 million, up 53.04% from the prior year.
  • Change in Receivables grew to $73.8 million in Q2 2026 per INCY's latest filing, from $27.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $128.5 million in Q4 2025 and bottomed at -$64.8 million in Q3 2022.
  • Historically, Change in Receivables has averaged $28.4 million across 5 years, with a median of $19.8 million in 2024.
  • The widest YoY moves for Change in Receivables: up 412.37% in 2025, down 1672.12% in 2025.
  • Over 5 years, Change in Receivables stood at $26.7 million in 2022, then soared by 223.31% to $86.3 million in 2023, then climbed by 12.05% to $96.7 million in 2024, then soared by 32.89% to $128.5 million in 2025, then plunged by 42.57% to $73.8 million in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods registered $73.8 million, $27.0 million, and $128.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 1.35 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 1.37 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn 117.58 Mn
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 73.80 Mn
10 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -1.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 73.80 Mn
Mar 31, 2026 27.03 Mn
Dec 31, 2025 128.50 Mn
Sep 30, 2025 53.00 Mn
Jun 30, 2025 20.23 Mn
Mar 31, 2025 -30.96 Mn
Dec 31, 2024 96.69 Mn
Sep 30, 2024 19.40 Mn
Jun 30, 2024 -6.48 Mn
Mar 31, 2024 1.97 Mn
Dec 31, 2023 86.29 Mn
Sep 30, 2023 19.27 Mn
Jun 30, 2023 14.21 Mn
Mar 31, 2023 -21.09 Mn
Dec 31, 2022 26.69 Mn
Sep 30, 2022 -64.78 Mn
Jun 30, 2022 120.62 Mn
Mar 31, 2022 -53.96 Mn
Dec 31, 2021 99.61 Mn
Sep 30, 2021 78.52 Mn